Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
Business Wire•02/11/2026•06:45 ET
0
Key Highlights
- ➤$150 million receivables sale program extended through October 2029
- ➤Facility size remains unchanged at $150 million
- ➤Accendra Health says extension supports liquidity strength
Expert Statements
Jonathan Leon, EVP and Chief Financial Officer of Accendra Health, Inc.
“We are pleased to have worked with our banking partner to extend the Receivables Sale Program until October of 2029. The facility size remains unchanged, further ensuring the Company’s liquidity strength, and we believe that this continued partnership demonstrates the strength of our accounts receivable portfolio and processes”
Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it executed an amendment to its Receivables Purchase Agreement (the “Receivables Sale Program”) on October 29, 2026. The amendment, among other things, extends the Scheduled Termination Date of the facility to October 2029, and the $150 million size of the Receivables Sale Program is unchanged.
Get started
Create a free account to read the full story.